Search Results - "Ballreich, Jeromie M"
-
1
Association between US Pharmacopeia (USP) monograph standards, generic entry and prescription drug costs
Published in PloS one (12-11-2019)“…Despite the importance of pharmacopeial standards, little is known regarding their effect on drug competition. Such information is of particular relevance…”
Get full text
Journal Article -
2
Examining Opportunities to Increase Savings From Medicare Price Negotiations
Published in JAMA internal medicine (01-06-2023)“…Allowing the US Centers for Medicare & Medicaid Services to negotiate prescription drug prices for Medicare may improve drug affordability. To estimate savings…”
Get more information
Journal Article -
3
Strategic Manufacturer Response to the Medicaid Rebate Cap Removal
Published in JAMA health forum (01-11-2024)“…This economic evaluation illustrates a manufacturer’s estimated spending and revenues as it discontinued a branded product and introduced a generic replacement…”
Get full text
Journal Article -
4
Coverage of Nonpharmacologic Treatments for Low Back Pain Among US Public and Private Insurers
Published in JAMA network open (05-10-2018)“…Despite epidemic rates of addiction and death from prescription opioids in the United States, suggesting the importance of providing alternatives to opioids in…”
Get full text
Journal Article -
5
Allocation of National Institutes of Health Funding by Disease Category in 2008 and 2019
Published in JAMA network open (04-01-2021)“…Prior research suggests an association between burden of disease and National Institutes of Health (NIH) funding. The allocation of NIH funding should reflect,…”
Get full text
Journal Article -
6
Trends of Prescription Drug Manufacturer Rebates in Commercial Health Insurance Plans, 2015-2019
Published in JAMA health forum (06-05-2022)“…This economic evaluation examines the magnitude and trend of prescription drug rebates in commercial markets from 2015 to 2019 and identifies insurance plan…”
Get full text
Journal Article -
7
Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers
Published in JAMA network open (01-06-2018)“…Despite unprecedented injuries and deaths from prescription opioids, little is known regarding medication coverage policies for the treatment of chronic…”
Get full text
Journal Article -
8
Utilization of Filgrastim and Infliximab Biosimilar Products in Medicare Part D, 2015-2019
Published in JAMA network open (01-03-2022)“…This cross-sectional study examines utilization trends for filgrastim and infliximab products and their biosimilars to understand whether biosimilars are…”
Get full text
Journal Article -
9
Biosimilar uptake of filgrastim and impact on spending in Medicare Part D from 2015 to 2019
Published in Journal of clinical oncology (01-10-2021)“…Abstract only 67 Background: The introduction of a filgrastim biosimilar in 2014 was associated with substantial cost savings in Medicare Part B and Medicaid…”
Get full text
Journal Article -
10
Association between US Pharmacopeia
Published in PloS one (12-11-2019)“…Despite the importance of pharmacopeial standards, little is known regarding their effect on drug competition. Such information is of particular relevance…”
Get full text
Journal Article -
11
The Trauma Collaborative Care Study (TCCS)
Published in Journal of orthopaedic trauma (01-04-2017)“…Previous research suggests that the care provided to trauma patients could be improved by including early screening and management of emotional distress and…”
Get full text
Journal Article -
12
A Prospective Randomized Trial to Assess Fixation Strategies for Severe Open Tibia Fractures: Modern Ring External Fixators Versus Internal Fixation (FIXIT Study)
Published in Journal of orthopaedic trauma (01-04-2017)“…The treatment of high-energy open tibia fractures is challenging in both the military and civilian environments. Treatment with modern ring external fixation…”
Get full text
Journal Article